Please assess the completion status of the following clinical trial:

Trial Title: Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* COPD over 40 years of age (30 to 60% post-bronchodilator FEV1 predictive value)~* Patients under Double~* Patients under triple therapy (for 1 Mo prior Screening)~Exclusion Criteria:~* Pregnant or lactating women~* Patients experiencing a COPD exacerbation requiring use of systemic steroids and/or antibiotics, hospitalization~* concommitant diseases impacting feasibility or safety

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Glyco 25 (Type: EXPERIMENTAL): BDP/FF (400/24 daily)+ Glyco 25µg daily
- Glyco 50 (Type: EXPERIMENTAL): BDP/FF (400/24 daily)+ Glyco 50 µg daily
- Glyco 100 (Type: EXPERIMENTAL): BDP/FF (400/24 daily)+ Glyco 100µg daily
- BDP/FF 400/24 (Type: ACTIVE_COMPARATOR): BDP/FF 400/24

Based on this trial design, predict the completion outcome and termination type (if applicable).